Lucideon's engineering biology strategy aims to leverage its materials consulting expertise to develop innovative solutions for pressing global challenges in healthcare and sustainability
Often referred to as synthetic biology, engineering biology involves designing and optimizing biological systems to create synthetic parts and processes. This approach holds the potential to revolutionize industries by addressing critical issues such as resource scarcity, environmental impact, and disease prevention.

Lucideon will apply its materials science expertise to accelerate the commercialization of groundbreaking technologies. Our comprehensive services include materials characterization, analytical assessment, formulation development, and biocompatibility assessment, ensuring that innovative biotech products are functional, safe, and scalable.
Anike Te, Chief Strategy Officer at Lucideon, stated, "Lucideon is capitalizing on decades of extensive materials science expertise and collaborating with industry leaders to support the development of novel materials and processes that can transform the biotechnology landscape. Our consultative approach and analytical capabilities are designed to bring engineering biology innovations to life."
About Lucideon
Lucideon is a leading development and commercialization organization specializing in materials technology, processes, and testing. Our team of scientists and engineers work together to provide innovative solutions that advance materials technology.
About Engineering Biology
Engineering biology encompasses the application of biological principles to design and develop materials and systems that address global challenges, including sustainability and healthcare. This emerging field holds significant promise for the future of materials innovation.
October 2024